
Commentary|Articles|February 5, 2026
Leading Breast Radiologists Discuss the Recent Lancet Study on AI and Interval Breast Cancer
Author(s)Jeff Hall
Wendie Berg, M.D., Stamatia Destounis, M.D., and Amy Patel, M.D., share their thoughts and perspectives on key findings from the Lancet mammography study on AI and interval breast cancer, and how they have incorporated AI into their practices.
Advertisement
Advertisement
Recently reported results from the randomized controlled Mammography Screening with Artificial Intelligence (MASAI) trial suggest that
Related to this article

Catch up on the top radiology content of the past week.

In the second of a two-part podcast episode, Lauren Nicola, MD, Christoph Wald, MD, PhD, MBA, and Peter Shen discuss challenges with evaluating value and ROI for AI software, the physician time required to do so, and possible solutions to facilitate improved clarity and consistency with AI reimbursement.

While AI tools abound in radiology, how many AI-enabled software products have incorporated insights from clinical radiologists?

In the first of a two-part podcast episode, Lauren Nicola, MD, Christoph Wald, MD, PhD, MBA, and Peter Shen discuss current challenges with reimbursement for AI in radiology.
Advertisement
Advertisement

